Virtu Financial’s Purple Biotech PPBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,899
Closed -$28K 2106
2025
Q3
$28K Buy
+4,899
New +$87.8K ﹤0.01% 1238
2024
Q3
Sell
-96
Closed -$8K 1772
2024
Q2
$8K Buy
96
+16
+20% +$1.86K ﹤0.01% 1152
2024
Q1
$11K Buy
+80
New +$11.5K ﹤0.01% 1243
2022
Q3
Sell
-69
Closed -$33K 2123
2022
Q2
$33K Buy
+69
New +$41.3K ﹤0.01% 1232
2021
Q2
Sell
-108
Closed -$89K 1956
2021
Q1
$89K Sell
108
-7
-6% -$6.53K 0.01% 1346
2020
Q4
$88K Buy
+115
New +$96.9K 0.01% 1098
2020
Q3
Sell
-54
Closed -$119K 1406
2020
Q2
$119K Buy
+54
New +$53.1K 0.01% 838
2019
Q4
$16K Buy
10
+4
+67% +$5.84K ﹤0.01% 1341
2019
Q3
$9K Buy
+6
New +$10K ﹤0.01% 1357
2019
Q2
Sell
-19
Closed -$47K 1762
2019
Q1
$47K Buy
19
+8
+73% +$19.3K ﹤0.01% 1220
2018
Q4
$15K Buy
+11
New +$27.7K ﹤0.01% 1405
2018
Q3
Sell
-6
Closed -$31K 2038
2018
Q2
$31K Buy
+6
New +$30K ﹤0.01% 1824
2018
Q1
Sell
-15
Closed -$67K 2445
2017
Q4
$67K Buy
+15
New +$67K ﹤0.01% 2013

Other funds holding PPBT

Virtu Financial's PPBT Position: Q4 2025 in Review

Virtu Financial sold out of Purple Biotech (PPBT) in Q4 2025, closing a stake of 4,899 shares — an estimated $28K sold.

Virtu Financial first reported a position in PPBT in Q4 2017 and held it in 13 quarters. The position peaked at $119K in Q2 2020. 19 funds tracked by Wall St. Rank hold PPBT as of Q4 2025.

  • Virtu Financial reported no remaining Purple Biotech position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 4,899 Purple Biotech shares in Q4 2025, an estimated $28K.
  • Virtu Financial first reported a position in Purple Biotech in Q4 2017 and held it in 13 quarters.
  • Virtu Financial's Purple Biotech position peaked at $119K in Q2 2020.
  • 19 funds tracked by Wall St. Rank held Purple Biotech as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.